Futura Medical is developing a portfolio of innovative products for two large markets, sexual health and pain.
Topical treatment for erectile dysfunction
CE mark granted as a medical device in the EU. Clear regulatory pathway as a medical device in the US with FDA endorsement of Phase 3 clinical study protocol FM71. First deal signed for China and South East Asia with discussions ongoing for the licensing rights in other territories as part of an agreed process managed by Futura’s advisers.